Coordinating HIV care and alcohol-use treatment efforts
Admin Core
It tests whether coordinated clinic-based care and a transdiagnostic cognitive behavioral therapy can help people living with HIV who drink too much and have mental health or substance-use problems.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11173874 on NIH RePORTER |
What this research studies
If you join, the program will bring together two research projects and supporting cores to deliver and refine alcohol-reduction and mental health treatments within HIV clinics. You might be offered a transdiagnostic cognitive behavioral therapy designed to address both drinking and common mental health symptoms. Study staff will track outcomes, safety events, and how well clinics can deliver the combined care. The administrative team coordinates site activities, regulatory oversight, and communication between clinics and investigators to keep the effort working smoothly.
Who could benefit from this research
Good fit: Adults living with HIV who drink at unhealthy levels and who receive care at participating HIV clinics, especially those with co-occurring anxiety, depression, or substance-use symptoms.
Not a fit: People without HIV, those who do not drink or have only minimal alcohol use, or those who cannot attend participating clinics are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this work could help people with HIV cut back on unhealthy drinking and improve mental health by providing integrated care at their regular HIV clinic.
How similar studies have performed: Related CBT-based and integrated interventions have shown promise in people with HIV, but implementing combined alcohol and mental health care in front-line HIV clinics is less well established.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cropsey, Karen L — University of Alabama at Birmingham
- Study coordinator: Cropsey, Karen L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.